Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,619 across all filing types
Latest filing 2022-04-27 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
北京德恒（深圳）律师事务所关于深圳市海王生物股份有限公司2022年第二次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the legality and procedural compliance of the 2022 second extraordinary general meeting (临时股东大会) of Shenzhen Haiwang Bioengineering Co., Ltd. It details the meeting's convening, attendance, voting procedures, and results. The document does not contain financial statements or management discussion but focuses on the legal validation of the shareholder meeting and its resolutions. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes and confirms the validity of the shareholder meeting proceedings.
2022-04-27 Chinese
监事会关于第八届监事会第十七次会议相关事项的意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from the Supervisory Board of Shenzhen Haiwang Bioengineering Co., Ltd. regarding guarantees provided to subsidiaries and associated companies. It discusses specific corporate governance matters related to financial guarantees but does not contain financial statements, earnings data, or regulatory certifications. It is not an announcement of a report publication, nor a transcript or voting result. The content fits best under Board/Management Information (MANG) as it relates to decisions and opinions from a company's supervisory board on corporate matters.
2022-04-11 Chinese
独立董事关于第八届董事局第二十六次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding a specific agenda item for an upcoming board meeting, specifically about a related-party loan transaction. It references governance rules and the company's articles, and it is dated just before the board meeting. The content is about board-level approval and governance matters, not a financial report, earnings release, or regulatory filing. It is not a report itself but a governance-related document expressing pre-approval opinions on a board agenda item. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions at the board or senior management level.
2022-04-11 Chinese
关于召开2022年第二次临时股东大会通知的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2022 second extraordinary general meeting of shareholders for Shenzhen Haier Bioengineering Co., Ltd. It includes information about the meeting date, voting procedures (including online voting), agenda items, registration details, and proxy authorization forms. There are no financial statements or financial performance data included. The document is primarily a notice to shareholders about the meeting and how to participate, which fits the definition of a Proxy Solicitation & Information Statement (PSI). The document length is about 4049 characters, which is sufficient for a detailed meeting notice but does not contain financial reports or voting results. Therefore, the classification is PSI with high confidence.
2022-04-11 Chinese
关于为参股公司提供同比例担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shenzhen Haiwang Bioengineering Co., Ltd. regarding providing proportional guarantees for loans to an associate company, Shandong Kangli Medical Device Technology Co., Ltd. It includes details about the guarantee amount, shareholder meeting approvals, financial status of the guaranteed company, and opinions from the board and independent directors. The document is a formal announcement about a financing-related guarantee arrangement, not a financial report, audit, or management discussion. It does not contain financial statements or earnings data but rather a disclosure of a capital/financing update related to guarantees. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 2210 characters, which is consistent with an announcement rather than a full report.
2022-04-11 Chinese
第八届监事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 17th meeting of the 8th Supervisory Board of Shenzhen Haiwang Bioengineering Co., Ltd. It details the meeting's convening, voting results, and references to related guarantee proposals that require shareholder approval. The content focuses on board/committee decisions and procedural compliance, without presenting financial statements or detailed financial data. It is not an annual or interim report, earnings release, or any form of financial report. It is also not a notice of voting results from a shareholder meeting but rather a supervisory board meeting resolution announcement. Therefore, the document fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies.
2022-04-11 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.